Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Toppozada M et al. Management of amenorrhea due to contraceptive injectables by temporary IUD insertion. 1982 Contracept Deliv Syst pmid:12338166
Molitor-peffer MP [Indications and medical survey of long acting progestatives used for contraception (author's transl)]. 1982 Contracept Fertil Sex (Paris) pmid:12338449
Statement on injectable contraception. 1982 IPPF Med Bull pmid:12338511
Rozenbaum H [Sex steroids and vascular risk]. 1983 Jan-Feb Coeur pmid:12339512
Neinstein LS and Katz B Contraception and cardiac disease: can the pill, IUD be prescribed? 1984 Contracept Technol Update pmid:12339673
Budden GC et al. Intra-uterine granulation tissue with an intra-uterine contraceptive device in situ for 16 years. 1985 J Obstet Gynaecol (Lahore) pmid:12340366
Chang MC Reminiscences on early pill development. 1986 Netw Res Triangle Park N C pmid:12341094
Coppens M and Thiery M Endometrial response to the use of a sequential oral contraceptive. 1988 J Obstet Gynaecol (Lahore) pmid:12342312
Gu HB [The effects and mechanism of norethisterone and megestrol on lipoprotein metabolism in rats]. 1991 Shengzhi Yu Biyun pmid:12343701
Rutter T The future for injectable contraceptives. 1993 Afr Health pmid:12344840
Future contraceptive methods. 1994 Contracept Rep pmid:12345631
Workshop on injectable contraceptives. 1994 Jul-Aug Glimpse pmid:12345890
Kaunitz AM Injectable contraception: the USA perspective. 1992 IPPF Med Bull pmid:12346920
Millions of couples to have choice of injectable contraceptive. 1996 Integration pmid:12347310
Garnero P et al. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. 2002 Hum. Reprod. pmid:12351557
Silva EG et al. Peritoneal lesions in guinea pigs treated with hormones. 2002 Int. J. Gynecol. Pathol. pmid:12352191
Pasapera AM et al. Norethisterone is bioconverted to oestrogenic compounds that activate both the oestrogen receptor alpha and oestrogen receptor beta in vitro. 2002 Eur. J. Pharmacol. pmid:12359276
Morabito N et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. 2002 J. Bone Miner. Res. pmid:12369794
Nayak RK et al. Ultrastructural effects of mestranol and norethindrone on guinea pig endometrial stromal cell. 1975 Am. J. Vet. Res. pmid:1238043
Abrahamsen B et al. Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6. 2003 Calcif. Tissue Int. pmid:12384814
Mueck AO et al. Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women. 2002 Maturitas pmid:12385856
Norris LA et al. Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. 2002 Maturitas pmid:12385861
Riis BJ et al. Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. 2002 Am. J. Obstet. Gynecol. pmid:12389012
Martinez G et al. Effect of norethisterone and its A-ring reduced metabolites on the acrosome reaction in porcine spermatozoa. 2002 Andrologia pmid:12390087
Facchinetti F et al. Hormone supplementation differently affects migraine in postmenopausal women. 2002 Headache pmid:12390622
Milewicz T et al. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor. 2002 Gynecol. Endocrinol. pmid:12396561
Grant EC Avoid hormones in gastrointestinal angiodysplasia. 2002 Lancet pmid:12401283
Döcke F et al. Studies on the mechanism of the ovulation-inhibiting effect of 19-norsteroids in cyclic rats. 1975 Endokrinologie pmid:1241669
Mackey JP A small double-blind trial of an anovulant agent in acne vulgaris. 1975 Ir Med J pmid:124309
Von Holst T et al. [Amenorrhea rate after switch from sequential hormone replacement therapy to continuous combined administration of low dose estradiol and norethisterone acetate]. 2002 Zentralbl Gynakol pmid:12439764
Skarda J Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice. 2002 Physiol Res pmid:12449440
pmid:12453162
Bladbjerg EM et al. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. 2002 Hum. Reprod. pmid:12456630
Beck P et al. Effect of contraceptive steroids on arginine- stimulated glucagon and insulin secretion in women. II. Carbohydrate and lipid physiology in insulin-dependent diabetics. 1976 Metab. Clin. Exp. pmid:1246206
Dickey RP and Stone SC Progestational potency of oral contraceptives. 1976 Obstet Gynecol pmid:1246375
Board JA Contraception with norethindrone 0.35 mg administered continuously. 1976 South. Med. J. pmid:1246653
Georgiev DB and Manassiev NA Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women. 2002 Jul-Aug Medscape Womens Health pmid:12466733
von Holst T et al. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone. 2002 Maturitas pmid:12468135
Beksinska ME and Rees HV Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa. 2001 Afr J Reprod Health pmid:12471932
Salobir BG et al. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women. 2002 Fertil. Steril. pmid:12477508
Anderson LC et al. An injectable sustained release fertility control system. 1976 Contraception pmid:1248260
Furlong LA Ectopic pregnancy risk when contraception fails. A review. 2002 J Reprod Med pmid:12497674
Bond FT et al. Synthesis and biological inactivity of some 4alpha,6-cyclo steroids. 1976 J. Med. Chem. pmid:1249805
Ence TJ et al. Heparin metabolism and heparin-release lipase activity during long-term estrogen-progestin treatment. 1976 Metab. Clin. Exp. pmid:1250155
Moore KH et al. The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers. 2002 Clin Ther pmid:12501881
Yamasaki K et al. Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. 2003 Toxicology pmid:12504345
Tang G et al. Controlled delivery system for norethindrone based on biodegradable poly-alpha,beta-(hydroxyalkyl)-DL-aspartamide. 2002 Oct-Dec Drug Deliv pmid:12511199
Givens JR et al. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. 1976 Am. J. Obstet. Gynecol. pmid:1251854
Boyd RA et al. The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy. 2003 J Clin Pharmacol pmid:12520628
Swanton AG and Paterson-Brown S Secondary amenorrhoea due to the use of rifampicin as an antimycobacterial agent. 2002 J Obstet Gynaecol pmid:12528712
Simon JA et al. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. 2003 Am. J. Obstet. Gynecol. pmid:12548201
Althuis MD et al. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. 2003 Br. J. Cancer pmid:12556959
Zouboulis CC and Piquero-Martin J Update and future of systemic acne treatment. 2003 Dermatology (Basel) pmid:12566804
pmid:12573798
Aussenac F et al. Cholesterol dynamics in membranes of raft composition: a molecular point of view from 2H and 31P solid-state NMR. 2003 Biochemistry pmid:12578350
pmid:12586323
Tibor F and Lajos B [Determination of synthetic gestagenic hormones by gas chromatography]. 1976 Acta Pharm Hung pmid:1258655
Kubli-Garfias C et al. Ab initio electronic structure of the progestogen norethisterone and its 5 alpha-derivatives. 2002 J. Steroid Biochem. Mol. Biol. pmid:12589946
Gambacciani M et al. Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. 2003 Maturitas pmid:12590012
Portman DJ et al. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. 2003 Am. J. Obstet. Gynecol. pmid:12592236
Neven P et al. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate. 2003 BJOG pmid:12618160
Li C et al. Low-dose hormone therapy and carbohydrate metabolism. 2003 Fertil. Steril. pmid:12620438
Gorgulu S et al. The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. 2003 Acta Cardiol pmid:12625488
pmid:12625700
Wu Z et al. Synthesis of tetrahydro-1,4-benzodiazepine-2-ones on hydrophilic polyamide SynPhase lanterns. J Comb Chem pmid:12625708
de Gooyer ME et al. Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. 2003 Steroids pmid:12628686
Muneyyirci-Delale O et al. Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate? 2003 Jan-Feb Int J Fertil Womens Med pmid:12643518
pmid:12662347
Doose DR et al. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. 2003 Epilepsia pmid:12681003
Martelli A et al. Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. 2003 Mutat. Res. pmid:12694747
Conner P et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. 2003 Breast Cancer Res. Treat. pmid:12725416
Squadrito F et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. 2003 Am. J. Med. pmid:12727580
Seeger H et al. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. 2003 Horm. Metab. Res. pmid:12734785
Suparto IH et al. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. 2003 Am. J. Obstet. Gynecol. pmid:12748457
Toppozada M et al. Uterine response to prostaglandin e2 under oral contraceptives. 1976 Contraception pmid:1277847
Goto T and Hiromi J Toxicity of 17alpha-ethynylestradiol and norethindrone, constituents of an oral contraceptive pill to the swimming and reproduction of cladoceran Daphnia magna, with special reference to their synergetic effect. 2003 Mar. Pollut. Bull. pmid:12787610
Christodoulakos GE et al. The effect of various regimens of hormone replacement therapy on mammographic breast density. 2003 Maturitas pmid:12787969
Anderson RA et al. Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men. 2003 J. Clin. Endocrinol. Metab. pmid:12788888
Stahlberg C et al. Hormone replacement therapy and risk of breast cancer: the role of progestins. 2003 Acta Obstet Gynecol Scand pmid:12790856
Rubinacci A et al. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. 2003 May-Jun Menopause pmid:12792297
Sidelmann JJ et al. Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study. 2003 BJOG pmid:12798469
Ellertson C et al. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. 2003 Obstet Gynecol pmid:12798518
Van Vliet HA et al. Biphasic versus monophasic oral contraceptives for contraception. 2003 Cochrane Database Syst Rev pmid:12804421
Van Vliet HA et al. Biphasic versus triphasic oral contraceptives for contraception. 2003 Cochrane Database Syst Rev pmid:12804457
Coyle D et al. Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptoms. 2003 Pharmacoeconomics pmid:12807367
pmid:12810304
pmid:12814882
pmid:12825966
pmid:12857102
Strandberg TE et al. Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women. 2003 Am. J. Cardiol. pmid:12860228
Fenkci V et al. The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study. 2003 Gynecol. Obstet. Invest. pmid:12865592
Arabi A et al. Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. 2003 Hum. Reprod. pmid:12871894
Barth A et al. Influence of ethinyloestradiol propanolsulphonate on serum bile acids in healthy volunteers. 2003 Exp. Toxicol. Pathol. pmid:12877349
pmid:12885229
pmid:12889912
Buckler H and Al-Azzawi F The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women. 2003 BJOG pmid:12892687
pmid:12899669
Jirapinyo M et al. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. 2003 Acta Obstet Gynecol Scand pmid:12911449
Biglia N et al. Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens. 2003 Maturitas pmid:12927315
Görög S Chemical and analytical characterization of related organic impurities in drugs. 2003 Anal Bioanal Chem pmid:12937879